Shin Nippon Biomedical Laboratories, Ltd. (2395) Stock Statistics & Valuation Metrics

Shin Nippon Biomedical Laboratories, Ltd. has a market cap or net worth of JPY 51.62B. The enterprise value is JPY 79.97B.

Market Cap

JPY 51.62B

Enterprise Value

JPY 79.97B

Shin Nippon Biomedical Laboratories, Ltd. has 41,632,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

41,632,400

Owned by Insiders

―

Owned by Institutions

4.14%

Shin Nippon Biomedical Laboratories, Ltd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 2.26%.

Return on Equity (ROE)

0.11

Return on Assets (ROA)

0.04

Return on Invested Capital (ROIC)

2.26%

Return on Capital Employed (ROCE)

0.04

Revenue Per Employee

19.36M

Profits Per Employee

2.72M

Employee Count

1,680

Asset Turnover

0.31

Inventory Turnover

1.10

The current PE Ratio of Shin Nippon Biomedical Laboratories, Ltd. is 8.93. Shin Nippon Biomedical Laboratories, Ltd.’s PEG ratio is 0.40.

PE Ratio

8.93

PS Ratio

1.44

PB Ratio

1.29

Price to FCF

0.00

Price to Operating Cash Flow

0.00

PEG Ratio

0.40

In the last 12 months, Shin Nippon Biomedical Laboratories, Ltd. had revenue of 32.52B and earned 4.57B in profits. Earnings per share was 109.69.

Revenue

32.52B

Gross Profit

15.83B

Operating Income

2.65B

Pretax Income

6.25B

Net Income

4.57B

EBITDA

6.09B

Earnings Per Share (EPS)

109.69

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow

0

Free Cash Flow

0

Free Cash Flow per Share

0.00

Shin Nippon Biomedical Laboratories, Ltd. pays an annual dividend of JPY 30.00, resulting in a dividend yield of 4.16%

Dividend Per Share

JPY 30.00

Dividend Yield

4.16%

Payout Ratio

44.72%

Free Cash Flow Yield

0.00%

Earnings Yield

11.41%

Beta

0.79

52-Week Price Change

-20.93%

50-Day Moving Average

1386.64

200-Day Moving Average

1366.49

Relative Strength Index (RSI)

33.98

Average Volume (3m)

294.83K

Shin Nippon Biomedical Laboratories, Ltd. upcoming earnings date is Jan 29, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 10, 2026

Next Earnings Date

Jan 29, 2027

Ex-Dividend Date

Mar 30, 2026

Shin Nippon Biomedical Laboratories, Ltd. as a current ratio of 1.09, with Debt / Equity ratio of 95.68%

Current Ratio

1.09

Quick Ratio

0.71

Debt to Market Cap

0.69

Net Debt to EBITDA

3.73

Interest Coverage Ratio

9.05

In the past 12 months, Shin Nippon Biomedical Laboratories, Ltd. has paid 1.71B in taxes.

Income Tax

1.71B

Effective Tax Rate

0.27

Shin Nippon Biomedical Laboratories, Ltd. EV to EBITDA ratio is 9.53, with an EV/FCF ratio of 0.00.

EV to Sales

2.11

EV to EBITDA

9.53

EV to Free Cash Flow

0.00

EV to Operating Cash Flow

0.00

Shin Nippon Biomedical Laboratories, Ltd. has JPY 14.33B in cash and marketable securities with JPY 37.58B in debt, giving a net cash position of -JPY 23.25B billion.

Cash & Marketable Securities

JPY 14.33B

Total Debt

JPY 37.58B

Net Cash

-JPY 23.25B

Net Cash Per Share

-JPY 558.45

Tangible Book Value Per Share

JPY 964.09

Gross margin is 50.71%, with operating margin of 10.61%, and net profit margin of 16.15%.

Gross Margin

50.71%

Operating Margin

10.61%

Pretax Margin

22.41%

Net Profit Margin

16.15%

EBITDA Margin

22.10%

EBIT Margin

12.10%

The average price target for Shin Nippon Biomedical Laboratories, Ltd. is JPY 1,387.00, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target

JPY 1,387.00

Price Target Upside

15.49% Upside

Analyst Consensus

Neutral

Analyst Count

1

Revenue Growth Forecast

1.89%

EPS Growth Forecast

22.53%

Smart Score

―

AI Score

59